2026–27 COVID-19 vaccine approvals and rollout uncertainty

FDA has approved four updated COVID-19 vaccines from Moderna, Pfizer, and Novavax targeting the XFG/JN.1 lineage, but narrower labeling and unsettled CDC/ACIP guidance are complicating implementation. New Mexico has pursued broad access through a standing order, while medical societies and the AAP continue broader recommendations amid questions about insurance, supply, pharmacy availability, and pregnancy and pediatric guidance.